Clinical decisions during early stages of cancer is well defined. However, as the patient moves into advanced stages of cancer where it becomes metastatic, un-resectable, post- primary treatment, the tumor generates complex disease biology and becomes difficult to treat. Cancer patient treatment guidelines mirror these changes and these guidelines too become complex, replete with multiple suggestions that the oncologist must choose based on their practice experience. Thus, the oncologist may administer the therapy combination to the patient without considering fully, the unique disease biology of that patient’s tumor. If the patient does not respond in a few cycles of therapy administration, the oncologist may replace it with a different therapy combination. Thus the therapy trial happens on the patient’s body.
OncoSphera Pvt Ltd addresses this problem and device technological innovations to suggest the best cancer therapy for each specific patient, everytime, during the advanced cancer treatment that treats the patient tumor. Thus, the trial of therapies on patient’s tumor will occur OUTSIDE the patient’s body, rather INSIDE. Thus, the patient does not have to tolerate the extreme side effects of various therapies while the best one is identified. It uses cell model technologies, genomics and artificial intelligence to identify the best suited therapy combination specific to every patient. Combining Cell Model technologies and Artificial Intelligence with Genomics can result into a precise therapy combination that will work for each of the different cancer patients.
